Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$1.23 - $2.07 $1.08 Million - $1.81 Million
-874,144 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$1.75 - $3.03 $558,173 - $966,436
-318,956 Reduced 26.73%
874,144 $1.59 Million
Q3 2021

Nov 05, 2021

SELL
$2.41 - $3.33 $66,742 - $92,221
-27,694 Reduced 2.27%
1,193,100 $3.33 Million
Q2 2021

Aug 05, 2021

SELL
$2.24 - $3.9 $681,421 - $1.19 Million
-304,206 Reduced 19.95%
1,220,794 $3.71 Million
Q4 2020

Feb 03, 2021

BUY
$3.06 - $4.17 $30,600 - $41,700
10,000 Added 0.66%
1,525,000 $4.74 Million
Q3 2020

Nov 03, 2020

BUY
$3.46 - $5.69 $1.83 Million - $3.02 Million
530,000 Added 53.81%
1,515,000 $5.35 Million
Q2 2020

Aug 12, 2020

BUY
$3.22 - $6.08 $64,400 - $121,600
20,000 Added 2.07%
985,000 $4.71 Million
Q1 2020

May 14, 2020

BUY
$3.3 - $6.84 $31,455 - $65,198
9,532 Added 1.0%
965,000 $3.34 Million
Q4 2019

Feb 05, 2020

BUY
$3.61 - $6.75 $3.45 Million - $6.45 Million
955,831 Added 100.08%
1,910,936 $11 Million
Q4 2019

Feb 05, 2020

SELL
$3.61 - $6.75 $3.45 Million - $6.45 Million
-955,468 Reduced 50.0%
955,468 $5.52 Million
Q3 2019

Nov 01, 2019

BUY
$4.62 - $7.11 $682,397 - $1.05 Million
147,705 Added 18.29%
955,105 $4.57 Million
Q2 2019

Jul 29, 2019

BUY
$5.68 - $8.68 $839,924 - $1.28 Million
147,874 Added 22.42%
807,400 $5.93 Million
Q1 2019

May 07, 2019

BUY
$7.27 - $9.07 $1.16 Million - $1.45 Million
159,526 Added 31.91%
659,526 $5.39 Million
Q4 2018

Feb 13, 2019

BUY
$6.59 - $14.47 $540,380 - $1.19 Million
82,000 Added 19.62%
500,000 $3.42 Million
Q3 2018

Nov 13, 2018

BUY
$10.55 - $15.28 $833,450 - $1.21 Million
79,000 Added 23.3%
418,000 $5.68 Million
Q2 2018

Aug 14, 2018

BUY
$5.04 - $17.96 $447,552 - $1.59 Million
88,800 Added 35.49%
339,000 $4.03 Million
Q1 2018

May 15, 2018

BUY
$5.12 - $11.77 $118,784 - $273,064
23,200 Added 10.22%
250,200 $1.39 Million
Q4 2017

Feb 14, 2018

BUY
$6.78 - $9.32 $1.54 Million - $2.12 Million
227,000
227,000 $2.08 Million

About Galmed Pharmaceuticals Ltd.


  • Ticker GLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,088,400
  • Market Cap $82M
  • Description
  • Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...
More about GLMD
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.